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Abstract 
Medication adherence of antiretroviral therapy (ART) is a critical factor of the quality of 
life in people living with HIV/AIDS. Near perfect levels of medication adherence is needed to 
optimally suppress viral load, though they are not frequently achieved.  African American 
women constitute as the biggest group of women living with HIV/AIDS. Currently, the 
relationship between medication adherence and African American HIV-positive women is not 
clearly understood, but is vital to the livelihood of this population. We performed a systematic 
review in order to understand what factors influence medication adherence in African American 
HIV-positive women. We examined peer-reviewed studies published between 2006 and 2016 
using a variety of databases. An initial search yielded 808 studies, of which 14 studies met our 
inclusion criteria.  Conspiracy beliefs, medical mistrust, social support, stigma, and depression 
appear to impact medication adherence in this population. Healthcare providers must foster 
trusting relationships with their patients, be able to identify barriers of emotional support, and 
address mental health in their treatment plans.  
Introduction 
Human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) 
continues to be a persistent public health issue on national and global levels. The World Health 
Organization (WHO) estimates that almost 78 million people have been infected with the HIV 
virus and 39 million people have died due to HIV infection (n.d.). As of 2015, there are about 37 
million people living with HIV/AIDS (PLWH) worldwide (Centers for Disease Control [CDC], 
2015a). The CDC further estimates 50,000 new cases of HIV/AIDS arise every year (2015a). 
Lastly, it is estimated that 658,507 people diagnosed with HIV/AIDS in the U.S. have died, even 
though HIV/AIDS treatment regimens are now more readily available (CDC, 2015a & Arts & 
Hazunda, 2012). These statistics demonstrate that the population of HIV-positive people 
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continues to grow and, despite developments in HIV/AIDS treatment regimens that can greatly 
improve HIV-infected people’s livelihood, the infection is still a sustained problem today.  
The diagnosis of HIV/AIDS has evolved from being perceived as a death sentence to a 
manageable disease. The National Institute of Allergy and Infectious Diseases (NIAID) defines 
HIV, or human immunodeficiency virus, as the virus that targets the body’s immune system by 
weakening T cells that fight off infections, which leads to the infected individual being more 
vulnerable to infections and other complications (2012). HIV can progress to AIDS, or acquired 
immunodeficiency virus, which is the final stage of HIV infection that is achieved when the 
infected individual has one or more infections subsequent to the immunocompromised state and 
a T cell count of less than 200 cells per millimeter of blood (NIAID, 2012). HIV/AIDS is 
transmitted through contact with bodily fluids such as blood, semen, vaginal, rectal discharge, 
and breast milk of a person with HIV and is therefore commonly transmitted through sexual 
contact, needle and syringe sharing, and pregnancy (CDC, 2015a). In the United States, more 
than 1.2 million people are living with HIV/AIDS (HHS, 2014). Men who have sex with men 
(MSM) of all races and ethnicities are the most affected group by HIV, accounting for 54% of all 
PLWH in 2011 (HHS, 2014). In 2010, white MSM made up the largest percentage of new HIV 
infections (HHS, 2014). Women accounted for 20% of new HIV infections in 2010 and 23% of 
those living with HIV in 2011 (CDC, 2015b). Hispanics and Latinos accounted for 20% of 
PLWH in 2011, while African Americans accounted for 41% (CDC, 2015b). Furthermore, 
African American women account for about 29% of new HIV/AIDS infections every year and 
represent an infection rate 20 times higher than Caucasian women and 5 times higher than 
Hispanic women (CDC, 2015c). 
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Treatment 
Advancements over recent decades have been made concerning HIV/AIDS treatment. 
Antiretroviral therapy (ART) has dramatically improved health trajectories for people affected 
by HIV/AIDS by reducing viral load and risk of transmission (Spivak & Planelles, 2015). Today, 
pharmacological intervention for HIV-positive individuals usually involves health care providers 
implementing an approach called highly active antiretroviral therapy (HAART), which combines 
drugs from at least 2 of the 6 available drug classes of ART in order to avoid creating viral 
strains that are resistant to single drugs (NIAID, 2013 & Mayo Clinic, 2015). The typical 
treatment regimen for PLWH is long term and can cause significant lifestyle changes because 
adherence to treatment critically influences the quality of life of PLWH.   
Adherence  
There are many contributing factors to one’s physical, emotional, and mental experience 
of HIV/AIDS. HIV/AIDS-infected people are expected to maintain a high degree of medication 
adherence in order to reduce serum viral load and maintain adequate immune status (Mayo 
Clinic, 2015). The Food and Drug Administration (FDA) defines medication adherence as the 
degree to which patients take medication as prescribed by their doctors by filling prescriptions 
regularly, taking the medication on time in the way it is meant to be taken, and understanding the 
directions concerning the medication given by one’s doctor (2015). PLWH are largely dependent 
on antiviral medications to manage their illness, as antiretroviral therapy (ART) have 
dramatically improved health trajectories by reducing HIV-related morbidity, mortality, and the 
likelihood of transmitting of the infection to a sexual partner while improving the manageability 
of daily living with HIV/AIDS (National Institute of Health, 2016). However, in order for people 
affected by HIV/AIDS to receive the maximum benefits from ART, they must maintain at least a 
95% adherence level to their medications (Peltzer & Pengpid, 2013). Moderate to low levels of 
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adherence leads to increased viral replication and low drug serum levels, which can result in viral 
mutations and therefore drug resistant strains of HIV. Resistant strains of the virus reduce the 
effect of ART on disease management and treatment. Furthermore, ineffective medication 
compliance leads to the increased risk of jeopardizing the effectiveness of future treatment 
regimens due to the drug resistant strains (Ribeiro, Sarmento e Castro, Dinis-Ribeiro, & 
Fernandes, 2015). Therefore, medication adherence is not only an individualized complication 
for each person affected by HIV/AIDS, but also a public health problem for the current and 
future HIV/AIDS populations. 
One’s ability to maintain optimal medication adherence is multifactorial and therefore 
can be difficult for health care providers to gauge. The FDA has identified that hard to remember 
medication schedules, unpleasant side effects, the possible lack of physical reminder of their 
illness, and unfamiliarity of the risk of drug resistance that can occur with skipped doses and 
irregular adherence are some of the main reasons PLWH are not adequately compliant with their 
medication regimen (2015). Various traits of an HIV-positive person also contribute to his or her 
ability to appropriately adhere with his or her medication regimen. One’s financial status, 
cognitive function, psychological state, and sociodemographic traits have all been identified as 
sources of influences in an individual’s life that contribute to his or her ability to maintain 
effective medication adherence (Katz, Ryu, Onuegbu, Psaros, Weiser, Bangsberg, & Tsai, 2013). 
Of these attributes, psychological and mental traits have been some of the most difficult to 
address by health care providers because these traits are typically addressed within an 
individual’s treatment regimen as symptoms of the illness, rather than social processes 
commonly experienced by HIV/AIDS-affected patients (Arnold, Rebchook, & Kegeles, 2014). 
Medication adherence can also be compromised due to the social stigma associated with 
HIV/AIDS, as many HIV-positive people feel ashamed and embarrassed of their disease status 
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because of the negative connotations that are associated with HIV/AIDS, such as reckless sexual 
behaviors and drug use (Szu-Szu & Holloway, 2015). 
Current research reveals that women have been shown to maintain lower adherence rates 
than men (Turner, Laine, Cosler, & Hauck, 2003) and African American females are more likely 
to encounter setbacks such as low income and lack of health insurance, which can negatively 
affect their medication adherence rates (Bozzette et al., 1998). There is limited research available 
that explores adherence in specifically African American females, rather than African Americans 
as a whole or African American men that have sex with men. It is evident that African American 
women make up a prominent group within the HIV/AIDS population and require research 
specific to them in order to address barriers and disadvantages they may face that prevent the 
achievement of optimal health outcomes, though a better understanding as to why low levels of 
adherence is prevalent in this population must be assessed first. Therefore, the purpose of this 
systematic review is to examine influential factors of medication adherence in the HIV-positive 
African American female population.   
Methods: Criteria, Search Strategy, and Data Sources 
The search criteria for the review were articles in English, peer-reviewed, and published 
within the past 10 years. Six data bases were searched for relevant literature: PubMed, CINAHL, 
Cochrane, Scopus, Google Scholar, and PsycInfo. The search terms used were “HIV”, “AIDS”, 
“medication adherence”, compliance, and “African-American”. Including keywords specifying 
gender, such as “women” or “female”, significantly reduced the body of literature available to 
screen and were therefore omitted from the search. Using these terms, the search yielded 123 
articles from PubMed, 32 articles from CINAHL, 59 articles from Cochrane, 457 articles from 
Scopus, 41 articles from Google Scholar, and 96 articles from PsycInfo.  
Study Selection 
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A total of 808 articles were yielded by the initial search through the six data bases. Using 
the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), an initial 
examination was conducted to remove duplicate articles and screen for relevance in the articles’ 
titles. Studies with emphasis on subjects like drug use, sexuality, and comorbidities or focused 
on only African-American men or black female HIV-positive populations outside of the United 
States were eliminated, as these topics are irrelevant to this review. Through this process, 24 
articles that met the search criteria were chose for further evaluation. A subsequent examination 
of the studies’ abstracts was conducted, resulting in the elimination of 10 studies, and yielded 14 
studies to be included in the review.  
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Data Extraction 
 
Table 1 depicts each study according to: author and year of publication, purpose, research 
design, methods, sample size, and findings.  
Results 
Based on the studies included in this review, five reoccurring themes that related to 
medication adherence in HIV-positive African American women were identified, including 
conspiracy beliefs, medical mistrust, social support, stigma, and depression. This paper will 
further explore how these factors influence medication adherence in HIV-positive African 
American women.  
Conspiracy Beliefs 
 One of the reoccurring barriers to medication adherence in HIV-positive African 
American women was the support of conspiracy theories. Conspiracy theories in relation to 
HIV/AIDS claim that HIV is a manmade virus and a treatment for HIV/AIDS exists, but is being 
withheld from the poor by the government. Conspiracy theories perpetuate misinformation 
within the HIV community about the effectiveness of pharmacologic regimens, leading endorsers 
of these theories to be less likely to adhere to them. Bogart et al. found that believing in 
conspiracy theories was associated with low medication adherence patterns among the study’s 
participants (2016). Furthermore, the study revealed that women and African American 
participants were more likely to believe in conspiracy theories, suggesting that medication 
adherence would be the most variable in these populations (Bogart et al., 2016).  
Medical Mistrust 
Another reoccurring barrier is medical mistrust, which researchers believe stems from the 
historical discrimination and unethical medical experimentation and exploitation of African 
Americans. Gaston and Alleyne-Green (2013) explain that African Americans fail to optimally 
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engage in healthcare because historical experiences of racism, discrimination, and unethical 
research practice has led to a general mistrust of the healthcare system, which can lead to the 
hindrance of building trusting relationships with healthcare providers and spread of 
misinformation among PLWH about treatment regimens. A 2009 study revealed that African 
Americans were more likely to discontinue ART because of changes in doctors and clinics, 
suggesting that the lack of continuity in healthcare services which hinders the development of 
trust between patients and their healthcare providers may not adequately support optimal 
medication adherence (Johnson et al., 2009). Furthermore, discrimination by healthcare 
providers also imposes difficulties with medication adherence. Peltzer, Domian, and Teel (2015) 
reveal in a study of young African American women living with HIV that discrimination by 
healthcare providers can be a humiliating experience and reduce one’s self worth. These feelings 
can result in a decrease in motivation to adherence to medication regimens and contributes to the 
mistrust between healthcare provider and patient.  
Social Support 
 Bogart et al. (2016) explains that the opinions of one’s social network can have the most 
impact on one’s health behaviors. Social support can affect medication adherence by acting as a 
buffer against barriers to adherence.  In an assessment of social networks among HIV-positive 
African Americans utilizing ART, nonadherence to ART decreased as frequency of interactions 
amongst social network members increased (Bogart et al., 2015). Furthermore, social support 
provides encouragement for PLWH. Though HIV-positive African American women often find 
themselves within a care taker dichotomy, in which they care for their significant others, family, 
and children while neglecting their needs, social support can ease the burden of disease PLWH 
struggle with daily and fulfill the need women who function as caretakers have to care for 
themselves by facilitating medication adherence through transportation to doctor appointments, 
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picking up prescriptions, and reinforcing the prescribed medication regimen schedule (Edwards, 
2006 & Peltzer, Domian, & Teel, 2015). Conversely, the lack of or turbulent support by social 
network members can isolate HIV-positive African American women, as their disease status 
labels them as abnormal in comparison to the members of their social network, or deteriorate 
coping abilities due to fluctuating feelings of security within social relationships (Edwards, 2006 
& Peltzer, Domian, & Teel, 2015). By lacking the feeling of being loved and cared for, many 
HIV-positive African American women felt less motivated to adhere to medication regimens 
since they could not effective cope with the stress of isolation (Edwards, 2006).  
Stigma 
Stigma can also negatively affect medication adherence in HIV-positive African 
American women because it compromises general psychological processes like adapting and 
coping (Katz et al., 2013). Adhering to a strict medication regimen is a physical identifier of one 
having a disease such as HIV/AIDS, and can lead to feelings of embarrassment and shame 
because of the perceived depiction of abnormality. According to multiple studies, these feelings 
have hindered medication adherence in African American women, in effort to suppress 
acknowledgement of living with a disease (Earnshaw, Bogart, Dovidio, & Williams, 2013, 
Edwards, 2006, & Katz et al., 2013). Additionally, fear of stigma often causes PLWH to avoid 
disclosing their disease status to their family and peers in order to avoid the discrediting or 
abnormal social label HIV/AIDS is associated with. Through cross sectional interview, Johnson 
et al. (2009) revealed that African Americans were more likely to discontinue ART to avoid 
disclosing disease status to others. Additionally, many HIV positive women blame perceived 
stigma for avoiding disclosure of disease status, which can impede coping skills that are 
necessary to achieve satisfactory quality of life (Ho & Holloway, 2015). By impeding the 
adapting and coping capabilities of HIV-positive African American women, stigma weakens the 
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perception of self-efficacy to properly adhere to medication regimens and may result in lapses in 
adherence (Sweeney & Vanable, 2016).  
Depression 
 Feelings of depression are common upon diagnosis of HIV, but can negatively impact the 
livelihood of PLWH if left unmanaged. Not only has depression been associated with decreased 
medication adherence, but it is also especially impactful on HIV-positive African American 
women, as they have been found to experience more psychological distress as a result of living 
with HIV in comparison to Caucasian women (Gaston & Alleyne-Green, 2013 & Ho & 
Holloway, 2015).  Depression in African American women often goes untreated because of the 
stigma surrounding mental illness and the fear of adding another medication to their already 
existent medication regimen and being admitted inpatient for treatment (Peltzer, Domian, & 
Teel, 2015). By not pursing adequate treatment for depression, African American women are 
more likely to become socially isolated and struggle with adaptive coping, which weakens the 
ability to optimally adhere to their medication regimens (Gaston & Alleyne-Green, 2013 & Katz 
et al., 2013).  
Conclusion 
 Conspiracy theories, medical mistrust, social support, stigma, and depression are all 
influential factors of medication adherence in the HIV-positive African American female 
population. Though factors of adherence were identified, some limitations of this study include 
lack of diversity in stages of disease and ages of participants, potential bias from studies that 
included personal narratives of participants, the small sample of research included in the review, 
and the majority of studies collecting data at one point in time.   
Given the identified barriers, changes in health care must be implemented in order to 
improve medication adherence patterns in African American women. A holistic health approach 
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when addressing the needs of HIV-positive patients should be incorporated in treatment plans to 
address not only their physical needs in terms of viral loads, but also psychological and mental 
health needs in terms of level of external support and coping skills against depressive symptoms. 
Additionally, healthcare providers must foster trusting relationships with their patients in order to 
support continuity of care and identify barriers of emotional support. Future research exploring 
the underlying mechanisms behind the increased psychological distress in African American 
women and medication adherence across the lifespan would also contribute to the understanding 
of medication adherence in HIV-positive African American women.  
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Table 1 Summary of findings  
AUTHOR (YEAR) PURPOSE RESEARCH 
DESIGN 
METHODS SAMPLE SIZE FINDINGS 
Bogart et al. (2016) To assess the 
relationship 
between 
communicated 
mistrust within 
social 
networks and 
treatment 
adherence 
among African 
Americans 
living with 
HIV 
 
Quantitative 
study 
 
Survey N=246 
 
Majority of 
participants were 
of low socio-
economic status, 
low annual 
incomes, and 
unemployed 
1. Medical mistrust may stem from history of 
discrimination 
 
2. social network members can promote healthy 
behaviors by communicating norms (i.e. condom 
use)  
 
3. Individuals with poor health behaviors and 
medical mistrust are more likely to believe in 
conspiracy theories 
 
4. When similar alters expressed conspiracy 
beliefs, 
participants exhibited lower treatment adherence 
 
5. Opinions of social network members who are 
similar in terms of age, gender, sero-status, 
sexual orientation, and race/ethnicity may have 
particular impact on people living with HIV 
 
6. On average, 64% of medications were taken as 
prescribed 
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Bogart et al (2015) 
 
 
To examine 
how 
characteristics 
of a social 
network 
affects stigma 
perception in 
African-
Americans 
living with 
HIV 
Quantitative 
study  
Baseline 
assessment of 
social network 
and statistical 
analysis 
N=147 1. Stigma and non-adherence was decreased 
among participants who increased the frequency 
of their interactions with alters over time 
 
2. Well-connected social networks have the 
potential to buffer the effects of stigma 
 
3. Blaming by alters decreased adherence 
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Charania et al. (2014).  To identify 
evidence-
based 
interventions 
for increasing 
HIV 
medication 
adherence 
behavior or 
decreasing 
viral load 
among persons 
living with 
HIV 
Qualitative 
study 
Systematic 
review 
N/A 1. Non-EBIs more often targeted 
specific populations (e.g., women, high-risk 
youth, MSM, and men).  
INFLUENTIAL FACTORS OF MEDICATION ADHERENCE IN THE             
HIV-POSITIVE AFRICAN-AMERICAN FEMALE POPULATION                                       
16 
Earnshaw, Bogart, 
Dovidio, and Williams. 
(2013).  
 
Stigma and racial/ethnic 
HIV disparities: 
Moving toward 
resilience. The 
American Psychologist. 
68 (4). 
 
 
 
 
 
To examine 
how 
mechanisms of 
stigma 
contribute to 
HIV-related 
disparities in 
risk, incidence 
and screening, 
treatment, and 
survival and 
what can be 
done to reduce 
the impact of 
stigma on 
these 
disparities 
 
Qualitative 
study 
 
 
 
 
 
 
 
 
 
 
 
 
 
Literature review 
and proposed 
agenda  
 
 
 
 
 
 
 
 
 
N/A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. Societal stigma contributes to racial and ethnic 
disparities in who acquires HIV, is aware of their 
sero-status, receives treatment, and dies early 
 
2. people with conflicting identities may be more 
likely to lack social support 
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Edwards (2006).  
 
To explore the 
relationship 
between 
perceived 
social support 
and HIV 
medication 
adherence in 
African 
American 
women 
Qualitative 
study 
Collected data 
via journals and 
interviews 
  
N=20 
 
Participants ages 
21-49 
1. A lack of true information about HIV feeds 
into stereotypes (i.e. drug user, promiscuous) 
about HIV by non-infected people 
 
2. Social relationships served as a distract from 
the idea of living with disease, but at times 
perpetuated stigma  
 
3. Taking meds is a physical and emotional 
identifier of having disease and causes 
embarrassment if the individual is amongst other 
people 
 
4. Participants identified need to feel loved and 
cared for in order to love and care for self 
 
5. Married participants jeopardized their own 
health and well-being to provide care and 
support for their husbands 
 
6. HIV stigma in the forms of social labeling, 
discrediting assumptions, and changing self-
identity can lead to self-hatred 
 
7. Relationship turbulence compromised social 
support and posed as a barrier to adherence 
 
8. Family decreases burden of disease by 
alleviating stress, providing distraction and 
encouragement, and facilitating 
normal environment  
 
9. Children provided motivation to take 
medication 
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Gaston and Alleyne-
Green (2013) 
 
To assess how 
attitudes about 
HIV in health 
care systems 
affect 
engagement of 
African 
Americans in 
care 
Qualitative 
study 
Systematic 
review 
 
N/A 1. African-Americans aren't optimally engaged 
in healthcare because of distrust of health care 
system secondary to racism, discrimination, and 
unethical research practice 
 
2. Healthcare providers must acknowledge 
historical relationship with health care system 
since  health care suspicion can lead to 
misinformation of HIV and HIV treatment 
 
3. Women and African-Americans are more 
likely to believe in conspiracy theories 
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Genberg, Lee, Rogers, 
and Wilson (2016).  
 
Four types of barriers to 
adherence of 
antiretroviral therapy 
are associated with 
decreased adherence 
over time." AIDS and 
Behavior, 19(1), 85-92.  
To gain 
understanding 
about how 
different types 
of barriers to 
adherence to 
antiretroviral 
therapy (ART) 
are related 
Quantitative 
study  
Randomized 
control trial of 
intervention + 
statistical 
analysis  
 
Barriers assessed: 
medication and 
health concerns, 
stigma, family 
responsibilities, 
problems with 
schedule/routine 
N=151 1. Average adherence was 73% 
 
2. At least 1 barrier to adherence was reported in 
70% of visits reported in the study, while 2 or 
more barriers were reported in 40% of the visits  
 
3. Perceived stigma was reported during 17% of 
study’s visits 
 
4. Labeling adherence as “intentional” simplifed 
patient’s psychosocial processes 
 
5. Barriers related to concerns about medications 
and health had a larger overall impact on 
adherence 
 
6. Higher number of depressive symptoms 
were associated with statistically significant 
decreases in objectively measured adherence 
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Ho and Holloway 
(2015) 
 
 
To examine 
how HIV-
related stigma 
affects lives of 
people living 
with 
HIV/AIDS 
 
Qualitative 
study 
Systematic 
review 
 
N/A 1. Stigma can cause psychological distress in 
HIV-positive women because of discrimination 
they have faced or worry over disclosing their 
status 
 
2. Stigma heightens rejection and may increase 
risky behaviors 
 
3. African-American women appear to 
experience more adverse psychological distress 
as a result of HIV-related discrimination 
compared to Caucasian women 
 
4. The cumulative effects of HIV- 
related stigma and pre-existing prejudices in 
relation to gender and race could collectively 
increase female psychological burden 
 
5. The underlying mechanism between 
HIV-related stigma and female psychological 
well-being remains unclear and is needed for 
future exploration 
 
6. The overuse of universal precautions impedes 
healthcare provider trust 
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Johnson et al. (2009) 
 
 
To identify 
group 
differences in 
self-reported 
reasons for not 
taking ART 
among a 
diverse sample 
of HIV-
infected men 
and women 
Qualitative 
study 
Cross sectional 
interviews 
N=3181 
 
1. 53% of African-American participants 
reported stopping ART 
 
2. Majority of women stopped using ART  
 
3. African-Americans were more likely to stop 
ART due to changes in healthcare providers or 
clinics 
 
4. African-Americans were more likely to 
endorse 
wanting to hide their HIV status as a reason for 
discontinuing ART  
 
5. Among those respondents who had never 
taken ART, there was an increased likelihood for 
African-Americans to report that they were 
waiting for their viral markers (CD4 and viral 
load) to worsen 
 
6. Women were more likely than men to have 
previously stopped ART 
Katz et al.   
(2013) 
 
To explore the 
relationship 
between HIV-
related stigma 
and ART 
adherence 
Qualitative 
studies 
Systematic 
review 
 
N/A 1. HIV can compromise relationships via social 
isolation 
 
2. Medication can give rise to physical stigma 
(i.e. blindness, skin rashes, herpes zoster) 
 
3. Adherence is economic burden on single 
women 
 
4. Stigma compromises general psychological 
processes like adapting, coping, and social 
support  
 
5. Adaptive coping is a critical factor for 
adherence 
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Konkle-Parker, Erlen, 
and Dubbert (2008) 
 
 Barriers and facilitators 
to medication 
adherence in a southern 
minority population 
with HIV disease. 
Journal of the 
Association of Nurses in 
Aids Care, 19 (2), 98-
104.  
 
To identify 
perceived 
barriers and 
facilitators for 
HIV 
medication 
adherence in a 
primarily 
African 
American, low 
income 
sample to 
support the 
development 
of an 
adherence 
intervention 
Qualitative 
study  
Group interviews N=20 1. Patient related barriers included burden of 
extra planning and remembering throughout the 
day, denial of disease status, life stress, side 
effects of medications (nausea, diarrhea, fatigue), 
and shame 
 
2. Facilitators of adherence included acceptance 
of diagnosis, thinking about consequences of not 
taking medications, prayer/spirituality, 
improvements of medications, trusting 
relationship with healthcare provider, and 
support from family and friends 
 
3. Stigma often results in loss of relationships 
and social rejection 
 
4. Personal ridicule led participants to feel need 
to hide diagnosis 
 
5. Shame associated with picking up medication 
and taking it at work 
 
6. Educating support system about diagnosis 
facilitated adherence 
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Peltzer, Domian, and 
Teel (2015)  
 
To explore 
lived 
experiences of 
young 
African-
American 
women living 
with HIV 
Qualitative 
study 
Patient 
interviews 
N=11 1. Social support facilitated self-care 
 
2. Participants did not feel normal living with 
HIV and tried to suppress acknowledgement of 
the disease 
 
3. Stigma and discrimination from healthcare 
professionals reduced self-worth and makes them 
feel dehumanized, humiliated, and isolated 
 
4. Feelings of depression and suicidal thoughts 
upon diagnosis were common and impeded 
healthy lifestyle 
 
5. Women taking ART were particularly resistant 
to taking medications, as antidepressants would 
be another medication to add to their 
complicated drug regimens  
 
6. Lack of transportation prevented support 
group engagement 
 
7,. African-American women often remain silent 
about depression, seeing it as a personal 
weakness, and many go undiagnosed with 
depression 
 
8. Women in the study worried about being 
admitted inpatient for depression and wouldn’t 
be able to care for kids 
 
9. Hiding disease status while feeling depressed 
further isolated participants 
 
10. Financial burden of self-care posed as a 
barrier 
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To synthesize  
findings 
regarding 
associations 
between 
stigma and 
adherence and 
discuss 
mechanisms 
of the stigma 
and adherence 
relationship 
Quantitative 
study 
Systematic 
review 
 
N/A 1. Possible links of stigma to medication 
adherence involve vulnerability to mental health 
difficulties (i.e. depression), reduction in self-
efficacy, and disclosure of disease status 
 
2. Internalized stigma may enhance vulnerability 
to 
mental health difficulties, such as depression, 
which impede adherence 
 
3. High levels of stigma may reduce self-efficacy 
of taking medications, which may impede 
adherence 
 
4. Stigma may cause depression, which can lead 
to inconsistent medication adherence 
Tufts (2015) 
 
To evaluate 
mHealth self-
management 
interventions 
that have been 
developed for 
African 
American 
HIV-positive 
women 
Qualitative 
study 
Systematic 
review 
 
- 1. Most evidence-based HIV behavioral 
interventions don’t holistically address elf-
management (i.e. frequency of clinic visits, diet, 
exercise, self-monitoring habits) 
 
2. African-American women account for higher 
proportion of HIV infections at all stages of the 
disease (44% of those living with HIV, 45% of 
newly infected per year, incidence rate is 20 
times higher than Caucasian women and 5 times 
higher than Hispanic) 
 
3. No mHealth HIV self-management studies 
conducted in the United States were specifically 
customized for use by HIV-infected African-
American women 
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